ProMab Biotechnologies, Inc

ProMab Biotechnologies, Inc is a revolutionizing biotechnology company that integrates cutting edge technologies to serve the global biomedical research community. We specialize in recombinant proteins, antibodies and engineered cell lines on which we are known to have built a superior reputation for quality and reliability. Our commitment to Excellence is exemplified by our newest service where we provide mRNA-LNP product and services that allows a swift and effective response to emerging infectious diseases. Join us in shaping the future of biotechnology and scientific progress. For more inquiries, visit our webiste: https://www.promab.com/. Email: info@promab.com

Monoclonal antibody production,stem cell,and cancer stem cell specific monoclonals and research reagents,recombinant protein expression in bacteria,insect,and mammalian systems,polyclonal antibody production,car t-cell products and services,car nk-cell products and services,antibody engineering,immunotherapy,hybridoma sequencing,gene synthesis,contract research organization,bispecific antibodies,scfv recombinant antibodies,human phage display library,human antibodies,t-cell activation beads,t-cell expansion media,peptide synthesis,and bispecific antibodies

Promab biotechnologies, inc operates in the Biotechnology industry.

Promab biotechnologies, inc's revenue is 11m - 100m

Promab biotechnologies, inc has 11 - 50 employees.